期刊文献+

地氯雷他定治疗56例慢性荨麻疹疗效观察 被引量:1

Fifty-six Cases of Curing Chronic Hives with the Help of Desloratadine
下载PDF
导出
摘要 目的观察地氯雷他定治疗慢性荨麻疹的疗效 ;方法采用开放式临床验证的方法 ;结果治疗观察 5 6例 ,显示瘙痒消退率 98.97% ,红斑消退率 98.82 % ,风团消退率 97.6 4% ,皮肤划痕征 10 0 %。结论地氯雷他定是一种治疗慢性荨麻疹有效的药物 ,且无明显的不良反应。 The purpose: observe the curative effects of using desloratadine to cure chronic hives;The method: adopt the method of open clinical verification; The result : After curing and observing fifty cases, it shows that the rate of itch disappearance is 98%; the rate of erythema disappearance is 99%;wheal disappearance 97%; dermatographism disappearance 100%.Conclusion :Desloratadine ia an effective drug for curing chronic hives without obvious side effects.
出处 《湖北职业技术学院学报》 2004年第3期84-85,共2页 Journal of Hubei Polytechnic Institute
关键词 慢性荨麻疹 地氯雷他定 疗效 瘙痒消退率 红斑消退率 chronic hives desloratadine observe curative effects
  • 相关文献

参考文献2

二级参考文献22

  • 1[1]Simons FER,Simons KJ. Clinical pharmacology of new histamine H1 antagonists[J]. Clin Pharmacokinet, 1999, 36: 329. 被引量:1
  • 2[2]Yumibe N, Huie K, Chen KJ, et al. Identification of human liver cytochrome P450 enzymes that metabolizethe nonsedating antihistamine loratadine. Formation ofdescarboethoxyloratadine by CYP3A4 and CYP2D6[J].Biochem Pharmacol, 1996, 51:165. 被引量:1
  • 3[3]Handley DA, Mccullough JR, Fang Y, et al. Descarboet-hoxyloratadine, a metabolite of loratadine, is a superiorantihistamine[J]. Ann Allergy Asthma Immunol, 1997,78(1):164. 被引量:1
  • 4[4]Anthes JC, Richard C, West RE, et al. Functional char-acterization of desloratadine and other antihistaminesin a Chinese hamster ovary(CHO)cell line that expressthe cloned human histamine H1 receptor and in humanbronchial smooth muscle cells(HBSNC)[J] .J AllergyClin Immunol, 2000, 105(1, Part 2): 1 125. 被引量:1
  • 5[5]Agrawal DK.Antiinflammator properties of deslorata-dine (DCL) :Effects on eosinophil chemotaxis, adhesionand release of superoxide anions[J].J Allergy Clin Im-munol, 2000, 105(1, Part 2): 49. 被引量:1
  • 6[6]Berthon B, Taudou G, Combettes L, et al. In vitro in-hibition, by loratadine and descarboethoxyloratadine, ofhistamine release from human basophils, and of histam-ine release and intracellular calcium fluxes in rat baso-philic leukemia cells (RBL-2H3)[J] .Biochem Phar-macol, 1994, 47: 789. 被引量:1
  • 7[7]Vignola AM, Crampette L, Mondain M, et al. Inhibito-ry activity of loratadine and descarboethoxyloratadineon expression of ICAM-1 and HLA-DR by nasal ep-ithelial cells[J]. Biochem Pharmacol, 1995, 52:200. 被引量:1
  • 8[8]Kreumer W, Hey JA, Anthes J, et al. Preclinical effica-cy and antiallergic profile of desloratadine, a selectiveand nonsedating histamine H1 receptor antagonist[J].J Allergy Clin Immunol, 2000, 105(1, Part 2): 1 118. 被引量:1
  • 9[9]Padhi D,Banfield C,Gupta S,et al. Multiple-dose pha-rmacokinetics, safety, and tolerance of desloratadine inhealthy volunteers[J] .J Allergy Ciin lmmunol, 2000,105(1, Part 2): 1 124. 被引量:1
  • 10[10]Herron JM,Padhi D,Affrime MB, et al. Dose-proport-ionality, linearity, and pharmacokinetics of desloratadi-ne in healthy adults[J]. J Allergy Clin Immunol, 2000,105(1,Part 2):1 126. 被引量:1

共引文献7

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部